Wednesday, June 10, 2009

Will Icahn’s Double Biotech Win Augur M&A Action?

Biogen Idec and Amylin both meet a few basic criteria that tend to make biotech companies appealing takeover targets.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)